Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus.
Peters
Jeffrey H
JH
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001471:Barrett Esophagus / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D003430:Cross-Sectional Studies; D016145:Endoscopy, Digestive System; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D004947:Esophagus / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006414:Hematoporphyrin Photoradiation; D006551:Hernia, Hiatal / Q000150:complications / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology* / Q000473:pathology; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology